Outcomes of patients with the third or higher relapsed classical Hodgkin lymphoma: results from the German Hodgkin Study Group

被引：6
作者：
Broeckelmann, P. J. [1 ]
Mueller, H. [1 ]
Kuecueksarioglan, E. [1 ]
Kaskel, P. [2 ]
Metterlein, V. [2 ]
Giezek, H. [3 ]
Balakumaran, A. [4 ]
Raut, M. K. [5 ]
Engert, A. [1 ]
von Tresckow, B. [1 ]
机构：
[1] Univ Hosp Cologne, Dept Internal Med 1, GHSG, Cologne, Germany
[2] MSD Sharp & Dohme GmbH, Haar, Germany
[3] MSD Europe Inc, Brussels, Belgium
[4] Merck Sharp & Dohme Corp, Rahway, NJ USA
[5] Merck Sharp & Dohme Corp, Kenilworth, NJ USA
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷 / 03期
关键词：
CELL TRANSPLANTATION; PHASE-II; MULTICOHORT; NIVOLUMAB; FAILURE;
D O I：
10.1093/annonc/mdz004
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：490 / 491
页数：2
相关论文
共 5 条
  • [1] [Anonymous], 2018, BLOOD, DOI DOI 10.1182/BL00D-2018-99-117045
  • [2] Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial
    Armand, Philippe
    Engert, Andreas
    Younes, Anas
    Fanale, Michelle
    Santoro, Armando
    Zinzani, Pier Luigi
    Timmerman, John M.
    Collins, Graham P.
    Ramchandren, Radhakrishnan
    Cohen, Jonathon B.
    De Boer, Jan Paul
    Kuruvilla, John
    Savage, Kerry J.
    Trneny, Marek
    Shipp, Margaret A.
    Kato, Kazunobu
    Sumbul, Anne
    Farsaci, Benedetto
    Ansell, Stephen M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (14) : 1428 - +
  • [3] Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma
    Chen, Robert
    Zinzani, Pier Luigi
    Fanale, Michelle A.
    Armand, Philippe
    Johnson, Nathalie A.
    Brice, Pauline
    Radford, John
    Ribrag, Vincent
    Molin, Daniel
    Vassilakopoulos, Theodoros P.
    Tomita, Akihiro
    von Tresckow, Bastian
    Shipp, Margaret A.
    Zhang, Yinghua
    Ricart, Alejandro D.
    Balakumaran, Arun
    Moskowitz, Craig H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (19) : 2125 - +
  • [4] Treatment of relapsed and refractory Hodgkin Lymphoma
    von Tresckow, Bastian
    Moskowitz, Craig H.
    [J]. SEMINARS IN HEMATOLOGY, 2016, 53 (03) : 180 - 185
  • [5] Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial
    Younes, Anas
    Santoro, Armando
    Shipp, Margaret
    Zinzani, Pier Luigi
    Timmerman, John M.
    Ansell, Stephen
    Armand, Philippe
    Fanale, Michelle
    Ratanatharathorn, Voravit
    Kuruvilla, John
    Cohen, Jonathon B.
    Collins, Graham
    Savage, Kerry J.
    Trneny, Marek
    Kato, Kazunobu
    Farsaci, Benedetto
    Parker, Susan M.
    Rodig, Scott
    Roemer, Margaretha G. M.
    Ligon, Azra H.
    Engert, Andreas
    [J]. LANCET ONCOLOGY, 2016, 17 (09) : 1283 - 1294
1